ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Shanghai Qishan Investment, a Tencent subsidiary, takes a stake in Beijing-based AI drug startup Aifei Zhiyu during an early-stage round. The company increased its registered capital to 12 million yuan, which equals approximately 1.79 million dollars. This move highlights Tencent's continued push into AI drug discovery.
Tap to vote and see what everyone thinks.
Summary by ByteBrief